| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lin,Qun | Chairman | 0.45% | |
| Jian,Du-Xian | Director | 0.57% | |
| Zhu,Yi-Wen | Director | 7.93% | Efficient Biomedical Corp. |
| Guo,Sheng-Zhu | Director | 0.10% | |
| Wu,Tian-Shang | Director | 0.08% | |
| Xu,Wen-Qi | Director | 0.00% | |
| Lin,Yu-Kuan | Independent Director | 0.00% | |
| Zhang,Zhen-Wu | Independent Director | 0.00% | |
| Zhu,Zhong-Qiang | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 265 | 5,082 | 6,923 |
| Operating cost | 1,005 | 2,643 | 2,971 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | -740 | 2,439 | 3,952 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | -740 | 2,439 | 3,952 |
| Operating expenses | 74,724 | 217,134 | 217,034 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -75,464 | -214,695 | -213,082 |
| Non-operating income and expenses | 3,629 | 2,402 | 1,514 |
| Net profit (loss) before tax | -71,835 | -212,293 | -211,568 |
| Income tax expense (benefits) | - | - | - |
| Net profit (loss) of ongoing business for the current period | -71,835 | -212,293 | -211,568 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -71,835 | -212,293 | -211,568 |
| Other comprehensive profit (loss), net | 229 | -24 | 297 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -71,606 | -212,317 | -211,271 |
| Net profit (loss) attributable to owners of parent company | -71,834 | -212,292 | -211,577 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -1 | -1 | 9 |
| Comprehensive profit (loss) attributable to owners of parent company | -71,613 | -212,316 | -211,294 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 7 | -1 | 23 |
| Basic earnings per share (yuan) | 0 | -2 | -2 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -91,157 | -194,884 | -185,665 |
| Net cash inflows (outflows) from investing activities | 70,000 | -176,737 | 186,951 |
| Net cash inflow (outflow) from financing activities | 4,766 | 496,902 | -409 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 72 | -24 | 25 |
| Increase (decrease) in cash and cash equivalents in the current period | -16,319 | 125,257 | 902 |
| Beginning balance of cash and cash equivalents | 160,155 | 34,898 | 33,996 |
| Ending balance of cash and cash equivalents | 143,836 | 160,155 | 34,898 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 607,632 | 689,287 | 386,383 |
| Non-current asset | 141,937 | 144,459 | 147,657 |
| Total asset | 749,569 | 833,746 | 534,040 |
| Current liability | 25,144 | 46,087 | 36,759 |
| Non-current liability | 13,300 | 14,538 | 18,165 |
| Total liability | 38,444 | 60,625 | 54,924 |
| share capital | 1,105,619 | 1,101,999 | 901,999 |
| Equity - secruity token | - | - | - |
| capital reserve | 1,178,055 | 1,172,906 | 870,580 |
| retained earning | -1,573,093 | -1,501,259 | -1,288,967 |
| Other equity | -788 | -1,850 | -5,822 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 709,793 | 771,796 | 477,790 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 1,332 | 1,325 | 1,326 |
| Total Equity | 711,125 | 773,121 | 479,116 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 6 | 7 | 5 |
